- Lid geworden
- 9 sep 2007
- Berichten
- 617
- Waardering
- 0
Weet er iemand of anavar naar het einde van een testkuur toe ook je shgb verlaagd of geldt dit enkel voor winny en mast?
-
Volg het forum via Google Nieuws
Anavar en shgb
- Topic starter vooruitdanmaar
- Startdatum
- Volgers 3
-
- Tags
- anavar oxandrolone
Bezoekers in dit topic
- Lid geworden
- 9 nov 2007
- Berichten
- 3.844
- Waardering
- 1
Volgens mij hangt het af van de dosering!
- Lid geworden
- 3 jul 2007
- Berichten
- 5.152
- Waardering
- 3
So why else may you keep such a high proportion of what you gained on ‘var? Well, I think it may be due to it’s relatively light impact on the HPTA, which brings me to my final point; Anavar will not totally shut down your HPTA, especially at lower doses (unlike testosterone, which will eventually do this even at a 100mg dose, or deca which will do it with a single 100mg dose). This could be due, at least partly, to the fact that Anavar doesn’t aromatize (convert to estrogen).
Serum testosterone, SHBG (Sex Hormone Binding Globulin), and LH (Leutinizing Hormone( will be slightly suppressed with low doses of Anavar, but less than with other compounds. FSH (Follicle Stimulating Hormone) , IGF1 (Insulin Like Growth Factor 1) and GH (Growth Hormone) will not be suppressed with a low dose of Anavar, but will actually be raised significantly (12)(13)(14) as you may have guessed, and LH will even experience a “rebound” effect when you stop using anavar (3) If your endocrine system and HPTA are funtioning normally, you should be able to use anavar with minimal insult to it, and can even keep most of your values within the normal range (5).
References:
1. Proj Inf Perspect. 1997 Nov;(23):19.
2. Burns. 2003 Dec;29(8):793-7
3. Clin Endocrinol (Oxf). 1993 Apr;38(4):393-8.
4. Int J Obes Relat Metab Disord 1995 Sep;19(9):614-24
5. jcem.endojournals.org/cgi/content/full/84/8/2705
6. Segal S, Cooper J, Bolognia J., Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity., J Am Acad Dermatol 2000 Sep;43(3):558-9
7. Demling RH., Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat., Wound Repair Regen 2000 Mar-Apr;8(2):97-102
8. J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72.
9. Demling RH, Orgill DP., The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury., J Crit Care 2000 Mar;15(1):12-7
10. Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, Wolfe RR, Herndon DN., Anabolic effects of oxandrolone after severe burn., Ann Surg 2001 Apr;233(4):556-64
11. Demling RH, DeSanti L., The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent., Burns 2001 Feb;27(1):46-51
12. Demling RH, DeSanti L., Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns., J Trauma 1997 Jul;43(1):47-51
13. Papadimitriou A, Preece MA, Rolland-Cachera MF, Stanhope R., The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth., J Pediatr Endocrinol Metab 2001 Jun;14(6):725-7
14. Doeker B, Muller-Michaels J, Andler W, Induction of early puberty in a boy after treatment with oxandrolone? Horm Res 1998;50(1):46-8
15. J Appl Physiol 96: 1055-1062, 2004. First published October 24, 2003; doi:10.1152/japplphysiol.00808.2003
8750-7587/04
16. James JS., Wasting syndrome: oral oxandrolone re-released in U.S., AIDS Treat News 1995 Dec 22;(no 237):3-4
17. Drugs. 2004;64(7):725-50.
18. Mt Sinai J Med. 1999 May;66(3):201-5.
Serum testosterone, SHBG (Sex Hormone Binding Globulin), and LH (Leutinizing Hormone( will be slightly suppressed with low doses of Anavar, but less than with other compounds. FSH (Follicle Stimulating Hormone) , IGF1 (Insulin Like Growth Factor 1) and GH (Growth Hormone) will not be suppressed with a low dose of Anavar, but will actually be raised significantly (12)(13)(14) as you may have guessed, and LH will even experience a “rebound” effect when you stop using anavar (3) If your endocrine system and HPTA are funtioning normally, you should be able to use anavar with minimal insult to it, and can even keep most of your values within the normal range (5).
References:
1. Proj Inf Perspect. 1997 Nov;(23):19.
2. Burns. 2003 Dec;29(8):793-7
3. Clin Endocrinol (Oxf). 1993 Apr;38(4):393-8.
4. Int J Obes Relat Metab Disord 1995 Sep;19(9):614-24
5. jcem.endojournals.org/cgi/content/full/84/8/2705
6. Segal S, Cooper J, Bolognia J., Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity., J Am Acad Dermatol 2000 Sep;43(3):558-9
7. Demling RH., Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat., Wound Repair Regen 2000 Mar-Apr;8(2):97-102
8. J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72.
9. Demling RH, Orgill DP., The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury., J Crit Care 2000 Mar;15(1):12-7
10. Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, Wolfe RR, Herndon DN., Anabolic effects of oxandrolone after severe burn., Ann Surg 2001 Apr;233(4):556-64
11. Demling RH, DeSanti L., The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent., Burns 2001 Feb;27(1):46-51
12. Demling RH, DeSanti L., Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns., J Trauma 1997 Jul;43(1):47-51
13. Papadimitriou A, Preece MA, Rolland-Cachera MF, Stanhope R., The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth., J Pediatr Endocrinol Metab 2001 Jun;14(6):725-7
14. Doeker B, Muller-Michaels J, Andler W, Induction of early puberty in a boy after treatment with oxandrolone? Horm Res 1998;50(1):46-8
15. J Appl Physiol 96: 1055-1062, 2004. First published October 24, 2003; doi:10.1152/japplphysiol.00808.2003
8750-7587/04
16. James JS., Wasting syndrome: oral oxandrolone re-released in U.S., AIDS Treat News 1995 Dec 22;(no 237):3-4
17. Drugs. 2004;64(7):725-50.
18. Mt Sinai J Med. 1999 May;66(3):201-5.
- Lid geworden
- 17 dec 2002
- Berichten
- 1.131
- Waardering
- 8
- Lengte
- 1m98
- Massa
- 127kg
- Vetpercentage
- 25%
Oxandrolon bindt ook eenvoudig aan SHBG.
- Lid geworden
- 9 nov 2007
- Berichten
- 3.844
- Waardering
- 1
- Lid geworden
- 17 dec 2002
- Berichten
- 1.131
- Waardering
- 8
- Lengte
- 1m98
- Massa
- 127kg
- Vetpercentage
- 25%
